201 BROOKLINE AVENUE, BOSTON, MA
Financial Results, Press Release
The Next Wave of Targeted Therapies in Oncology
Appoints Sung Lee to Board of Directors
Material disclosure
Reports Third Quarter 2025 Financial Results and Provides Business Highlights
Tango Therapeutics Enters Underwriting Agreement for $182.5 Million Offering
Investor Presentation
Changes in Board, Management or Compensation
FY 2025
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
S-3ASR
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Free Writing Prospectus
Submission Upload